Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 4, 2000, Pages 263-269

  Brown, Lindsay ^a   Ooi, Sze Yuan ^a   Lau, Kevin ^a   Sernia, Conrad ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

adrenoceptors; Deoxycorticosterone acetate salt hypertensive rats; Forskolin; Noradrenaline; Theophylline

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCIUM CHLORIDE; DEOXYCORTICOSTERONE ACETATE; FORSKOLIN; NORADRENALIN; POTASSIUM CHLORIDE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CHRONOTROPISM; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; INOTROPISM; MALE; NONHUMAN; RAT; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; CALCIUM CHLORIDE; CARBACHOL; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HEART; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL CONTRACTION; NEPHRECTOMY; NOREPINEPHRINE; PAPILLARY MUSCLES; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; SODIUM CHLORIDE; SYSTOLE; THEOPHYLLINE; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0034081620     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03234.x     Document Type: Article

References (41)

1. 2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure. Pharmacol. Rev. 1991; 43: 203-42.
2. 2. Brown L, Deighton NM, Bals S et al. Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J. Cardiovasc. Pharmacol. 1992; 19: 222-32.
3. 3. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc. Res. 1998; 39: 89-105.
4. 4. Böhm M, Beuckelmann D, Diet F, Feiler G, Lohse MJ, Erdmann E. Properties of cardiac alpha-and beta-adrenoceptors in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch. Pharmacol. 1988; 338: 383-91.
5. 5. Amos G, Kerr D, Sernia C, Brown L. β-Adrenoceptor antagonism and the hyperthyroid rat heart. J. Cardiovasc. Pharmacol. 1994; 24: 336-43.
6. 6. de Champlain J, Krakoff L, Axelrod J. Interrelationships of sodium intake, hypertension, and norepinephrine storage in the rat. Circ: Res. 1969; 25 (Suppl. 1): I-75-92.
7. 7. Heller LJ, Prohaska JR. Cardiac norepinephrine and intrinsic properties of isolated hypertrophied hearts from DOCA hypertensive rats. J. Mol. Cell Cardiol. 1984; 16: 987-93.
8. 8. Yamamoto J, Tsuchiya M, Saito M, Ikeda M. Cardiac contractile and coronary flow reserves in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1985; 7: 569-77.
9. iα in cardiac hypertrophy due to acquired hypertension. Hypertension 1992; 20: 103-12.
10. 10. Anand-Srivastava MB, de Champlain J, Thibault C. DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am. J. Hypertens. 1993; 6: 72-5.
11. 2-adrenoceptors in rat models of acquired hypertension. J. Cardiovasc. Pharmacol. 1989; 13: 421-31.
12. 12. Woodcock EA, Funder JW, Johnston CI. Decreased cardiac β-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. Circ. Res. 1979; 45: 560-5.
13. 13. Bockman CS, Jeffries WB, Pettinger WA, Abel PW. Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension. Hypertension 1992; 20: 304-13.
14. 14. Suzuki H, Kondo K, Saruta T. Inhibitory effect of K on blood pressure in DOCA-salt hypertensive rats. Acta Endocrinol. 1981; 97: 525-32.
15. 15. Mäkynen H, Arvola P, Vapaatalo H, Pörsti I. High calcium diet effectively opposes the development of deoxycorticosterone-salt hypertension in rats. Am. J. Hypertens. 1994; 7: 520-8.
16. 16. Marchant C, Brown L, Sernia C. Renin-angiotensin system in thyroid dysfunction in rats. J. Cardiovasc. Pharmacol. 1993; 22: 449-55.
17. 17. Brown L, Sernia C, Newling R, Fletcher P. Comparison of inotropic and chronotropic responses in rat isolated atria and ventricles. Clin. Exp. Pharmacol. Physiol. 1991; 18: 753-60.
18. 2+ exchange. Naunyn Schmiedebergs Arch. Pharmacol 1991; 344: 220-4.
19. 19. Hoey A, Marchant C, Brown L, Atwell R, Sernia C. Cardiac β-adrenoceptors in experimental hyperthyroidism in dogs. Clin. Exp. Pharmacol. Physiol. 1992; 19: 761-6.
20. 20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1977; 72: 248-54.
21. 21. Munson PJ, Rodbard D. LIGAND. A versatile computerized approach for the characterization of ligand-binding systems. Anal. Biochem. 1980; 107: 220-8.
22. 22. Brody MJ, Varner KJ, Vasquez EC, Lewis SJ. Central nervous system and the pathogenesis of hypertension. Sites and mechanisms. Hypertension 1991; 18 (Suppl. III): III-7-12.
23. 23. Soltis EE, Newman PS, Olson JW. Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension. Hypertension 1991; 18: 85-92.
24. A receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br. J. Pharmacol. 1995; 114: 925-30.
25. 25. Tordoff MG. Voluntary intake of calcium and other minerals by rats. Am. J. Physiol. 1994; 267: R470-5.
26. 26. Matsumara Y, Hashimoto N, Taira S et al. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Hypertension 1999; 33: 759-65.
27. 1 receptor antagonism and protection against cardiovascular end-organ damage. J. Hum. Hypertens. 1998; 12: 301-9.
28. 28. Morano I, Adler K, Weismann K, Knorr A, Erdmann E, Böhm M. Correlation of myosin heavy chain expression in the rat with cAMP in different models of hypertension-induced cardiac hypertrophy. J. Mol. Cell Cardiol. 1993; 25: 387-94.
29. 29. Foster KA, Hock CE, Reibel DK. Altered responsiveness of hypertrophied rat hearts to alpha-and beta-adrenergic stimulation. J. Mol. Cell Cardiol. 1991; 23: 91-101.
30. 30. Ayobe MH, Tarazi RC. Reversal of changes in myocardial β-receptors and inotropic responsiveness with regression of cardiac hypertrophy in renal hypertensive rats (RHR). Circ: Res. 1984; 54: 125-34.
31. 31. Brown L, Sernia C, Newling R, Fletcher P. Cardiac responses after norepinephrine-induced ventricular hypertrophy in rats. J. Cardiovasc. Pharmacol. 1992; 20: 316-23.
32. 32. Calderone A, Oster L, Moreau P, Rouleau J-L, Stewart DJ, de Champlain J. Altered protein kinase C regulation of phosphoinositide-coupled receptors in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994; 23: 722-8.
33. 33. Larivière R, Deng LY, Day R, Sventek P, Thibault G, Schiffrin EL. Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat. J. Mol. Cell Cardiol. 1995; 27: 2123-31.
34. 34. Chen K, Zhang X, Dunham EW, Zimmerman BG. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension. Hypertension 1996; 27: 85-9.
35. 35. Bockmann CS, Jeffries WB, Pettinger WA, Abel PW. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension. Am. J. Physiol. 1992; 262: H1752-8.
36. 36. Gauqelin G, Schiffrin EL, Cantin M, Garcia R. Specific binding of atrial natriuretic factor to renal glomeruli in DOCA-and DOCA-salt-treated rats: Correlation with atrial and plasma levels. Biochem. Biophys. Res. Commun. 1987; 145: 522-31.
37. 37. Schiffrin EL, St Louis J. Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats. Hypertension 1987; 9: 504-12.
38. 38. Hart MN, Heistad DD, Brody MJ. Effect of chronic hypertension and sympathetic denervation and wall/lumen ratio of cerebral vessels. Hypertension 1980; 2: 419-23.
39. 39. Schiffrin EL. Vascular receptors for angiotensin, vasopressin, and atrial natriuretic peptide in experimental hypertension. Can. J. Physiol. Pharmacol. 1989; 67: 1118-23.
40. 40. Soltis EE, Field FP. Extracellular calcium and altered vascular responsiveness in the deoxycorticosterone acetate-salt rat. Hypertension 1986; 8: 526-32.
41. 41. Obiefuna PCM, Ebeigbe AB, Sofola OA, Aloamaka CP. Altered responses of aortic smooth muscle from Sprague-Dawley salt-induced hypertension. Clin. Exp. Pharmacol. Physiol. 1991; 18: 813-18.